--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------------------------------------------------------------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Cleveland BioLabs, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
185860-10-3
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2006
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|_| Rule 13d-1(c)
|x| Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP NO. 185860-10-3
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
ChemBridge Corporation
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
--------------------------------------------------------------------------------
NUMBER OF SHARES 5 SOLE VOTING POWER
BENEFICIALLY 622,224
OWNED BY --------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH: --------------------------------------------------------
7 SOLE DISPOSITIVE POWER
622,224
--------------------------------------------------------
8 SHARED DISPOSITIVE POWER
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
622,224
--------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.1%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
CO
CUSIP NO. 185860-10-3
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Eugene Vaisberg
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
--------------------------------------------------------------------------------
NUMBER OF SHARES 5 SOLE VOTING POWER
BENEFICIALLY 622,224
OWNED BY --------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH: --------------------------------------------------------
7 SOLE DISPOSITIVE POWER
622,224
--------------------------------------------------------
8 SHARED DISPOSITIVE POWER
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
622,224
--------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.1%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
Item 1(a). Name of Issuer:
Cleveland BioLabs, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
11000 Cedar Ave.
Suite 290
Cleveland, Ohio 44106
Item 2(a). Name of Person Filing:
1. ChemBridge Corporation
2. Eugene Vaisberg
This Schedule 13G is filed by ChemBridge Corporation on behalf of itself and Mr.
Vaisberg pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934.
Attached as Exhibit 1 is an agreement between ChemBridge Corporation and Mr.
Vaisberg that this Schedule 13G is filed on behalf of each of them.
Item 2(b). Address of Principal Business Office or, if None, Residence:
The address of the principal business office of each of the
Reporting Persons is:
16981 Via Tazon, Suite G
San Diego, California 92127
Item 2(c). Citizenship:
ChemBridge Corporation is an Illinois corporation.
Eugene Vaisberg is a citizen of the United States of America.
Item 2(d). Title of Class of Securities:
Common Stock, $0.005 par value per share
Item 2(e). CUSIP Number:
185860-10-3
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or
13d-2(b) or (c), check whether the person filing is a:
Not applicable
Item 4. Ownership
The information contained in Items 5 - 11 of each of the
cover pages is incorporated herein by reference.
Eugene Vaisberg, the Chairman and Chief Executive Officer of
ChemBridge Corporation, is the majority owner of ChemBridge
Corporation and has the power to vote and dispose of
securities owned by ChemBridge Corporation. Accordingly, he
may be deemed to beneficially own the securities owned by
ChemBridge Corporation. Mr. Vaisberg disclaims any beneficial
ownership of the securities owned by ChemBridge Corporation.
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following |_|.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company
Not applicable
Item 8. Identification and Classification of Members of the Group
Not applicable
Item 9. Notice of Dissolution of Group
Not applicable
Item 10. Certification
Not applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date: February 27, 2007 CHEMBRIDGE CORPORATION
/s/ Sergey Altshteyn
----------------------------------------
Name: Sergey Altshteyn
Title: President
EXHIBIT 1
JOINT FILING AGREEMENT
The undersigned persons hereby agree that the Schedule 13G to which this Joint
Filing Agreement is attached is being filed on behalf of each of the undersigned
persons in accordance with Rule 13d-1(k)(1).
Date: February 27, 2007 CHEMBRIDGE CORPORATION
/s/ Sergey Altshteyn
----------------------------------------
Name: Sergey Altshteyn
Title: President
Date: February 27, 2007 EUGENE VAISBERG
/s/ Eugene Vaisberg
----------------------------------------
Name: Eugene Vaisberg